Taking this into consideration, we can suggest that ESPL1 and RAD54L, which are differentially expressed between the primary TNBC and PAAC and the metastatic PRAD and COAD, are modulating the cell cycle in various ways. This evidence concerns the gene RAD54L and prostate adenocarcinoma.